Ecnoglutide Outperforms Semaglutide in Weight Loss Study

In a new head-to-head study, ecnoglutide, a new weight loss drug, showed it could help people lose 35% more weight than the current drug, semaglutide. The trial involved 163 participants in China and revealed that ecnoglutide also significantly reduced waist size, which could be great news for those battling central obesity. What does it mean for you? If you're looking to shed some pounds, this new drug might offer a more effective option in the future, helping you not just lose weight but also trim down that stubborn waistline.

Original source Read the full story →
More from this briefing
Looney Tunes Land Opens at Six Flags Strategic Surprises: The Unseen Threats Unveiled Racial Abuse in Soccer: Time for Real Change AI Bias Challenges LGBTQ+ Rights and Privacy Victorian Solution to Burnout: Winter in France Serbia and NATO Unite for Pan-Domain Military Exercise Digital Twins Revolutionize Environmental Management Climate Change Threatens Global Food Security Fox News Viewing Linked to "Great Replacement" Beliefs

Get stories like this every morning.

Five-minute intelligence briefing — in your inbox at 6 AM.

Subscribe now